Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Scientific Reports
|
February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
Sara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Scientific Reports
|
December 21, 2021
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
Sara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Pediatrics
|
July 25, 2007
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021
Ross E McKinney, John Rodman, Chengcheng Hu, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 20, 2024
Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Xiajing Chu, Jason Wang, Leonardo Ologundudu, et al.
JAMA Dermatology
|
October 8, 2025
Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review
Xiajing Chu, Javeria Mubasher, Lina Chen, et al.
Cancer Discovery
|
January 8, 2025
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Charles A Ishak, Sajid A Marhon, Naïri Tchrakian, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Scientific Reports
|
February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
Sara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Scientific Reports
|
December 21, 2021
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
Sara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Pediatrics
|
July 25, 2007
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021
Ross E McKinney, John Rodman, Chengcheng Hu, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 20, 2024
Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Xiajing Chu, Jason Wang, Leonardo Ologundudu, et al.
JAMA Dermatology
|
October 8, 2025
Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review
Xiajing Chu, Javeria Mubasher, Lina Chen, et al.
Cancer Discovery
|
January 8, 2025
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Charles A Ishak, Sajid A Marhon, Naïri Tchrakian, et al.
Page
of 4